ZK

Zaher Karim Prasla

Active Director Director DIN 10759905
DIN 10759905 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Zaher Karim Prasla

Data last updated:

Zaher Karim Prasla is a Director at Laxina Pharma Private Limited (since 2024). The company operates in Pharma. Laxina Pharma Private Limited reported revenue of ₹1.62 Cr (FY 2025).

DIN 10759905
Primary Designation Director
Industry Pharma
First Appointment 29 Aug 2024
Oldest Company Age 2 yrs
Largest company Laxina Pharma Private Limited · ₹1.62 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Laxina Pharma Private Limited U47721MH2024PTC416532
Director29 Aug 20242024₹1.62 Cr (FY 2025)Active

Board colleagues of Zaher Karim Prasla

Directorship timeline

Open interactive timeline →
Laxina Pharma Private Limited
Premium access

Shareholding and investment profile for Zaher Karim Prasla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zaher Karim Prasla

Zaher Karim Prasla currently holds 1 directorship: Laxina Pharma Private Limited (Director, since 29 Aug 2024, revenue ₹1.62 Cr (FY 2025)).

Zaher Karim Prasla was first appointed on 29 Aug 2024 as Director at Laxina Pharma Private Limited.

The current boards of Zaher Karim Prasla's companies include Manoj Kumar Singh (Laxina Pharma Private Limited), Vipulkumar Bharatbhai Patel (Laxina Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available